Faculty who have authored publication Safety results from a pooled analysis of randomized, controlled phase II and III clinical trials and interim data from an open-label extension trial of the interleukin-12/23 monoclonal antibody, briakinumab, in moderate to severe psoriasis.
| Name | Title | Department | Institution |
|---|---|---|---|
| Kenneth Brian Gordon MD | Chair, Professor | Dermatology | Medical College of Wisconsin |
